TRANSMEMBRANE SENSING DEVICE FOR SENSING BLADDER CONDITION

• US 20100240949A1
• Filed: 06/07/2010
• Published: 09/23/2010
• Est. Priority Date: 07/29/2005
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Gerber, Martin T.
• Granted Patent: US 7,930,034 B2
• Time in Patent Office: Days
• US Class Current: 600/30
• CPC Class Codes: A61B 5/204 Determining bladder volume
• CPC Class Codes: A61B 5/686 Permanently implanted devices, e.g. pacemakers, other stimulators, biochips A61B5/6861 takes precedence
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control

Abstract

The disclosure describes a sensing device that is implantable to sense bladder conditions, as well as a neurostimulation system and method that make use of such a sensor for alleviation of urinary incontinence. The sensing device is implantable outside the bladder, but includes a lead that penetrates the bladder wall to deployed a sensor within the bladder. Using the sensor on the lead, the sensing device outside the bladder is able to detect a condition within the interior of the bladder. In this sense, the sensing device provides transmembrane sensing of internal bladder conditions. The condition may be indicative of bladder filling or bladder contraction, and may be used to control electrical stimulation applied to the patient to alleviate urinary incontinence.

Claims

1. A method comprising:

sensing a bladder condition via a sensor carried on a distal end of a lead, the sensor positioned within an interior of the bladder, the lead having an electrical conductor therein, and the lead extending from the interior of the bladder to a sensing device implanted outside of the bladder via penetration of a wall of the bladder; and

transmitting the sensed bladder condition via wireless communication to an implanted stimulator that is configured to deliver stimulation therapy for urinary incontinence based on the sensed bladder condition,

wherein the implantable stimulator and sensing devices are separate devices.

2. The method of claim 1, further comprising generating information based on the sensed bladder condition, wherein transmitting the sensed bladder condition via wireless communication comprises transmitting the information via wireless communication.

3. The method of claim 2, wherein the sensed bladder condition includes one of bladder size or bladder pressure.

4. The method of claim 3, wherein the information indicates at least one of a bladder fill level or bladder contraction.

5. The method of claim 2, further comprising transmitting the information to an external programmer that is configured to control the implanted stimulator to deliver stimulation therapy for urinary incontinence based on the information.

6. The method of claim 5, further comprising controlling via the external programmer delivery of stimulation therapy to a patient in response to at least one of the information or a patient input.

7. The method of claim 2, further comprising storing the information within the sensing device.

8. The method of claim 2, wherein the sensor comprises an impedance sensor configured to detect impedance within the bladder, and the information indicates a bladder fill level.

9. The method of claim 2, further comprising controlling the delivery of stimulation therapy by the implanted stimulator to a patient in response to the information to alleviate urinary incontinence.

10. The method of claim 1, further comprising attaching the sensing device to an exterior surface of the bladder.

11. The method of claim 1, wherein the sensing device includes a power supply.

12. The method of claim 1, further comprising delivering neurostimulation therapy from the implanted stimulator via at least one electrode implanted proximate to at least one of a sacral or pudendal nerve.

13. The method of claim 1, wherein the sensor includes one of an impedance sensor, an ultrasonic sensor, or a pressure sensor.